U.S. federal trademark · Serial No. 90310251 · Reg. No. 7422401
Development of pharmaceutical preparations and medicines; medical and scientific research in the field of vascular and cardiovascular impairments; medical and scientific research in the field of allogeneic cell therapy; medical and scientific research in the field of regenerative medicine; providing medical and scientific research information in the field of regenerative medicine, vascular and cardiovascular impairments, and allogenic cell therapies; medical and scientific research in the field of treatment and prevention of critical limb ischemia, diabetic foot ulcer, peripheral artery disease, diabetic retinopathy, age-related macular degeneration, heart failure, stroke, traumatic brain injury, acute kidney injury, acute respiratory distress syndrome, bronchopulmonary dysplasia
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.